S4 Ep7: Goodwin Attorneys Discuss Updates to Biosimilars Litigation Guide - a podcast by Not So Different: a Podcast from The Center for Biosimilars

Before the battle for market share gets started, the courtroom is the OK Corral for biosimilar developers and reference product manufacturers, who duke it out over patents  to determine how soon biosimilars can enter the marketplace. We spoke with Alexandra Valenti, JD, and Rob Cerwinski, JD, Goodwin partners and senior editors of the updated Guide to Biosimilars litigation and Regulation in the US about some of the key developments.

Further episodes of Not So Different: a Podcast from The Center for Biosimilars

Further podcasts by Not So Different: a Podcast from The Center for Biosimilars

Website of Not So Different: a Podcast from The Center for Biosimilars